Kawasaki Disease.
Selmek K, Harding M.
Pediatr Rev. 2024 Jul 1;45(7):425-427. doi: 10.1542/pir.2023-006051.
Mucocutaneous lymph node syndrome.
Odom RB, Olson EG.
Arch Dermatol. 1977 Mar;113(3):339-40.
Kawasaki disease. Mucocutaneous lymph node syndrome or MCLS.
Kawasaki T.
Acta Pathol Jpn. 1982;32 Suppl 1:63-72.
Mucocutaneous lymph node syndrome: a new disease.
[No authors listed]
Br Med J. 1977 Feb 12;1(6058):407. doi: 10.1136/bmj.1.6058.407.
Kawasaki Disease.
Son MBF, Newburger JW.
Pediatr Rev. 2018 Feb;39(2):78-90. doi: 10.1542/pir.2016-0182.
Mucocutaneous lymph node syndrome (Kawasaki disease).
Riley HD Jr.
J Infect Dis. 1976 Sep;134(3):302-5. doi: 10.1093/infdis/134.3.302.
Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome).
Landing BH, Larson EJ.
Am J Cardiovasc Pathol. 1987;1(2):218-29.
Post-COVID-19 Kawasaki-Like Syndrome.
Lechien JR, Hervochon R, Hans S.
Ear Nose Throat J. 2023 Jun;102(6):NP291-NP293. doi: 10.1177/01455613211006011. Epub 2021 Mar 26.
Kawasaki disease.
Kawasaki T.
Int J Rheum Dis. 2014 Jun;17(5):597-600. doi: 10.1111/1756-185X.12408.
Kawasaki disease.
Sundel RP.
Rheum Dis Clin North Am. 2015;41(1):63-73, viii. doi: 10.1016/j.rdc.2014.09.010.
